Adding new vaccine type to leading immunotherapy dramatically reduced melanoma recurrence
The combination of an experimental mRNA vaccine with an immunotherapy reduced the likelihood of melanoma recurring or causing death by 44% when compared to immunotherapy alone, a new clinical trial shows.
Apr 16, 2023
0
67